A short tour of the p-medicine Ontology Annotator Tool
A short tour of the p-medicine Ontology Annotator Tool
Choosing personalised treatment options based on molecular evidence
ecancermedicalscience editor's choice for November 2014
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients
The work and aims of SPECTA for better clinical trials
Update on post-operative complications in older patients
Cancer Core Europe: Consortium to address the care-research continuum challenge
EORTC and the management of clinical trial data
Molecular targeting in cancer and the impact on personalised medicine
Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the real world: Introduction
Current treatment options in mRCC
Discussion: Additional treatment options impact first-line treatment of mRCC